FDA approval of medications. What it really means.

Disclaimer: This paper is for informational and educational purposes only, based on research available as of early 2026. It does not provide medical advice or endorse the use of unapproved compounds.

This information is for informational purposes only and does not replace professional medical advice. Always consult a licensed healthcare provider for concerns about your health.

When people talk about peptides they focus on the Disclaimer: These products are for laboratory research and scientific purposes only. They are not FDA-approved for human consumption. 

The problem is that just because the FDA approves a medication that doesn’t mean it’s safe.

Post-Market Reality: The Frequency of FDA Drug Withdrawals

The FDA (Food and Drug Administration) is often viewed as the final gatekeeper of medical safety, yet approval is not always the end of the story. While the agency oversees over 20,000 approved prescription drug products, a small but significant percentage of these medications are eventually discontinued or withdrawn from the market due to emerging safety risks or lack of benefit.

The Numbers Behind Discontinued Drugs

Historical data and academic studies suggest that while mass withdrawals are rare, post-market safety issues are relatively common:

• Withdrawal Rate: A study of new drugs approved between 1990 and 2009 found that 4.2% (22 out of 528) were eventually withdrawn.

• Safety Flags: A broader Yale-led study indicated that nearly one-third (32%) of new FDA-approved drugs are flagged for a new safety issue after they reach the market. Most of these issues result in "black-box" warnings or safety announcements rather than total removal.

• Accelerated Approvals: Medications approved through accelerated programs face higher withdrawal rates. Between 2009 and 2022, 23% of oncology-related indications granted accelerated approval were eventually withdrawn because they failed to show clinical benefit.

• Recalls: In the last decade alone, the FDA has recorded more than 14,000 drug recalls. While many are for minor manufacturing issues, some target entire classes of unapproved or ineffective medications, such as the 2011 recall of roughly 500 unapproved cold and allergy drugs.

Why are Approved Drugs Discontinued?

A drug is typically removed when its risks outweigh its benefits. While commercial reasons—like low demand—account for many discontinuations, the most critical removals stem from safety toxicities discovered during routine use in the general population:

1. Hepatic Toxicity: Liver damage is the leading cause, responsible for roughly 21% of safety-related withdrawals.

2. Cardiotoxicity: Heart-related issues, such as rhythm abnormalities or increased risk of heart attack, account for about 6% of withdrawals.

3. Lack of Efficacy: Some drugs, particularly those with "accelerated approval," are withdrawn after years of use if follow-up trials fail to prove they actually help patients.

Notable Historical Withdrawals

Several high-profile cases illustrate how long it can take for safety issues to trigger a withdrawal:

Drug Name	Primary Use	Year Withdrawn	Reason for Withdrawal
Vioxx (Rofecoxib)	Pain Relief	2004	Increased risk of heart attack and stroke
Meridia (Sibutramine)	Weight Loss	2010	Cardiovascular risks
Darvon & Darvocet	Pain Relief	2010	Heart rhythm abnormalities (on market 55 years)
Thalidomide	Sedative/Morning Sickness	1957 (global)	Severe birth defects
Phenylpropanolamine	Decongestant	2000	Hemorrhagic stroke risk

The "Orange Book" and Discontinued Lists

The FDA maintains a Discontinued Drug Product List as part of its "Orange Book". This list is updated monthly to include products that are no longer marketed or have had their approvals withdrawn for reasons other than safety. As of early 2026, the FDA continues to refine these lists, recently adding specific dose variants of drugs like Ondansetron and Bromocriptine mesylate for safety reasons.

References

1.     Over 30% of FDA-Approved Drugs a Threat to Health and Safety, Finds Report https://www.sokolovelaw.com/blog/fda-approved-drugs-safety-threat/

2.     Aduhelm and the Politics of Drug Approval in the United States https://academic.oup.com/ppar/article-abstract/32/2/66/6574415?redirectedFrom=PDF

3.     New safety concerns identified for 1 in 3 FDA-approved drugs https://news.yale.edu/2017/05/09/new-safety-concerns-identified-1-3-fda-approved-drugs

4.     FDA-Approved Prescription Drugs Later Pulled from the Market https://mgaleg.maryland.gov/cmte_testimony/2021/ecm/1Pd6xUtoZIDCtnzLIa-mg5OTUvmdrfdhi.pdf

5.     Era Of Faster FDA Drug Approval Has Also Seen Increased Black-Box Warnings And Market Withdrawals https://www.healthaffairs.org/doi/10.1377/hlthaff.2014.0122

6.     Drug recalls are common. Does that mean that our medications are unsafe? https://www.health.harvard.edu/blog/drug-recalls-are-common-202303292907

7.     FDA recalls about 500 medicines: Which made list, and why? https://www.cbsnews.com/news/fda-recalls-about-500-medicines-which-made-list-and-why/

8.     It Takes the FDA 46 Months to Withdraw a Failed Drug with Accelerated Approval https://ldi.upenn.edu/our-work/research-updates/it-takes-the-fda-46-months-to-withdraw-a-failed-drug-with-accelerated-approval/

9.     Comparison of Drug Withdrawal Processes in the U.S. and Other Nations https://pmc.ncbi.nlm.nih.gov/articles/PMC9120009/

10.  Drugs withdrawn from the market due to cardiotoxicity https://www.researchgate.net/figure/Drugs-withdrawn-from-market-due-to-cardiotoxicity-up-to-May-2020_fig1_350099634

11.  Predictors of withdrawal of anticancer drug indications granted accelerated approval: a retrospective cohort study https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(25)00020-3/fulltext

12.  How many FDA Approved drugs have been withdrawn and why are aspiring drugs abandoned? https://crib.pharmacy.purdue.edu/research/how-many-fda-approved-drugs-have-been-withdrawn-and-why-are-aspiring-drugs-abandoned

13.  Additions/Deletions for Prescription and OTC Drug Product Lists https://www.fda.gov/drugs/drug-approvals-and-databases/additionsdeletions-prescription-and-otc-drug-product-lists